Optimise programmes

This Optimise programme has now been withdrawn
Some of the guides and additional resources have been removed as they may now be out of date. You can still provide feedback and complete the badge.

Best-value biological medicines: Focus on the position of biosimilar medicines

Released: 14/07/2020

Programme withdrawn

This programme has been withdrawn. The materials are no longer available to access but you can still submit feedback and earn the badge.

Best-value biological medicines: Focus on the position of biosimilar medicines

Programme withdrawn

This programme has been withdrawn. The materials are no longer available to access but you can still submit feedback and earn the badge.

Earn the badge

Once you have completed your small group learning, let us know the completion date and provide some feedback on your experience of using this CPPE Optimise programme. In return, we will award you with a badge of completion!

Once you have submitted your feedback, click Next to continue with this programme.

You must be logged in to do this.

Best-value biological medicines: Focus on the position of biosimilar medicines

Next steps

Now you have finished the small group learning complete the next steps below.

Reflect on what you need to do next. Are you ready to respond to a clinician or patient if you are asked about best-value biological and biosimilar medicines? What are the opportunities to ensure best practice locally? You may want to complete some extra learning or look at your local treatment pathways in more detail.

You may find it useful to read the NHS England document What is a biosimilar medicine? in full and to watch the full video interview with the patient and expert pharmacists to give you more insight in to how to support patients considering a switch in their biological medicine.

This learning could form the starting point for a record of revalidation.

Content contributors

Dale Arm-Riding, patient
Idris Bobat, pharmacy homecare lead and medication safety, Gloucestershire Hospitals NHS Foundation Trust
Stephen Brown, regional pharmacist, NHS England/NHS Improvement, South West and South East England
Anna Pracz, senior medicines optimisation pharmacist, Greater Manchester Health and Care Commissioning
Vanessa Reid, lead specialist clinical pharmacist, specialist medicine (dermatology, immunology, gastroenterology and rheumatology), Manchester University Foundation Trust
Caron Underhill, biologics pharmacist, University Hospital Southampton NHS Foundation Trust

CPPE programme developer

Liz Reid, lead pharmacist, learning development

CPPE reviewers

Samantha White, deputy director
Karen Wragg, regional manager, South Central

External reviewers

Clare Hardy, senior pharmacist – biologics, Chesterfield Royal Hospital NHS Foundation Trust
Sally James, divisional lead pharmacist for unscheduled care, Royal Liverpool University Hospital

CPPE editor

Paddy McLaughlin, editor

Piloted by

Alison Fryer, Salford Royal NHS Foundation Trust
Bilal Jabbar, Avicenna Medical Practice, Bradford

Brand names and trademarks

CPPE acknowledges the following brand names and registered trademarks mentioned throughout this update: Benepali ®, Enbrel ®, Hulio ®, Humira ®

References

NHS England. Medicines Value Programme. www.england.nhs.uk/medicines/value-programme/
Medicines and Healthcare products Regulatory Agency. Drug Safety Update. Biosimilar products. Feb 2008; Vol 1, Issue 7: 8. www.gov.uk/drug-safety-update/biosimilar-products/
Medicines and Healthcare products Regulatory Agency. Black triangle scheme. 2019. www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals#black-triangle-scheme
Medicines and Healthcare products Regulatory Agency. Drug Safety Update. Reporting suspected adverse drug reactions to vaccines and biological medicines. November 2012, vol 6, issue 4: H1. www.gov.uk/drug-safety-update/reporting-suspected-adverse-drug-reactions-to-vaccines-and-biological-medicines
NHS England. What is a biosimilar medicine? 2019. www.england.nhs.uk/publication/what-is-a-biosimilar-medicine/

NHS priorities

Clinical pharmacy

Public health

CPPE Optimise programmes

Best-value biological medicines: Focus on the position of biosimilar medicines

Programme withdrawn

Best-value biological medicines: Focus on the position of biosimilar medicines

Programme withdrawn

Earn the badge

Best-value biological medicines: Focus on the position of biosimilar medicines

Next steps

Learning pathways

Quick links

Useful links